STEINMETZ MICHAEL

CIK 000116628517 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001166285

Recent Transactions

50 trades

Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$30.67/sh−13,420→ 3,509,459 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Sale
AERIE PHARMACEUTICALS INC
Common Stock
2015-01-05$31.11/sh−10,200→ 3,499,259 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ReShape Weightloss Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.13/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Purchase
ReShape Weightloss Inc.
Series A Non-Voting Convertible Preferred Stock
2010-09-30$1.72/sh+704,607→ 704,607 total
Purchase
ARYx Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2010-09-30$0.01/sh+500,000→ 500,000 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Other
EPIRUS Biopharmaceuticals, Inc.
Common Stock
2010-01-01−7,913,653→ 14,633,961 total
Sale
Pharmasset Inc
Common Stock
2008-06-19$19.92/sh−100→ 2,119,831 total

Companies

Recent Filings

4
AERIE PHARMACEUTICALS INC
Jan 6, 2015

Address

C/O MPM ASSET MANAGEMENT 111 HUNTINGTON AVE., 31ST FLOOR

BOSTON, MA, 02199

View on SEC.gov